Sunteți pe pagina 1din 23

FILARIASIS

ELIMINATION
PROGRAM
FILARIASIS
- Also known as Elephentiasis
- is a parasitic disease caused by
an infection with roundworms of
the Filarioidea type.

It has an incubation period of 8-16


months
• INCUBATION PERIOD: 8- 16 months
• MODE OF TRANSMISSION: Mosquito Bites
ASYMPTOMATIC ACUTE STAGE: CHRONIC STAGE:
STAGE:
Presence of microfilariae Lymphadenitis, Hydrocele
in blood lymphangitis
No s/ sx for years Funiculitis, epididymitis, Lymphedema
orchitis
Elephantiasis
HYDROCELE
LYMPHEDEMA
ELEPHENTIASIS
COMPLICATIONS
• Blindnessby
Onchoceriasis
• Kidney Damage
• Sexual Dysfunction
DIAGNOSIS AND TREATMENT
• Circulating Filarial Antigen
• Nocturnal Blood Examination
• Immunochromanographic Test/ ICT
• PE, History Taking
IVERMECTIN
ALBENDAZOLE
DEC ( Diethylcarbamazine)-
Drug of Choice: “ Filariasis sugpuin, gamut ay
HETRAZAN inumin. Isang beses sa isang
taon sa loob ng limang taon”
DIAGNOSIS AND TREATMENT
• Surgery may be performed to remove surplus tissue
and provide a way to drain the fluid around the
damaged lymphatic vessels. Surgery may also be
used to minimize massive enlargement of the
scrotum.
• Elephantiasis of the legs can also be eased by
elevating the legs and providing support with
elastic bandages.
• DEC-fortified salt is helpful.
NURSING MANAGEMENT
• Health education and information
dissemination as to the MOT must
be carried out.
• Enviromental sanitation and the
destruction of breeding places of
mosquitoes must be emphasized.
• Personal hygiene must be
encouraged.
• The course of the disease must be
explained to the client and his/her
family.
PREVENTION AND CONTROL

• Use of mosquito nets


• Use of mosquito repellants
• Take a yearly dose of medicine
that kills the worms circulating
in the blood.
NATIONAL FILARIASIS
ELIMINATION PROGRAM
• Vision : Healthy and productive individuals and families for
Filariasis Free Philippines
• Mission: Elimination of Filariasis as a public health problem
through a comprehensive approach and universal access to
quality health services.
• Program Goal: Elimination of Filariasis as a public health
problem in the Philippines, by reaching atleast 85% MDA
coverage among the target population in all established areas.
OBJECTIVES
• To sustain transmission interruption in provinces through
strengthening of surveillance
• To intensify interventions and interrupt transmission in persistent
infection provinces
• To strengthen Morbidity Management & Disability Prevention
(MMDP) activities and services to alleviate suffering among chronic
patients
• To strengthen the health system capacity to secure LF elimination
• Secure adequate investment from governmental and non-
governmental sources to sustain all program objective
PROGRAM COMPONENTS
• Filariasis is a major parasitic infection, which continues to be a
public health problem in the Philippines. It was first discovered in
the Philippines in 1907 by foreign workers.
• Consolidated field reports showed prevalence rate of 9.7% per
1000 population in 1998.
• It is the second leading cause of permanent and long-term
disability.
• The disease affects mostly the poorest municipalities in the country
about 76% of the case live in the 4th-6th class type of
municipalities.
PROGRAM COMPONENTS
• The World Health Assembly in 1997 declared “Filariasis
Elimination as a priority” where the WHOs call for
global elimination was created (WHA 50.29 Resolution:
Elimination of Lymphatic Filariasis as a public health
problem)
PROGRAM COMPONENTS
• This was followed by the Global Program for Elimination of
Lymphatic Filariasis, launched by World Health Organization
which has 2 main components that were adopted by the national
program:

1. INTERRUPTION TRANSMISSION
2. CONTROL AMD REDUCE THE MORBIDITY
PROGRAM COMPONENTS
• A sign of the DOH's commitment to eliminate the disease, the
program's strategy shifted from control to elimination strategies
was evident in an Administrative Order no. 25-A, s. 1998 issued
in 2004.
• A major strategy of the Elimination Plan was the Mass Annual
Treatment using the combination drug, Diethylcarbamazine
Citrate and Albendazole for a minimum of 5 years to individual
ages 2 years old and above living in established endemic areas
after the issuance from WHO of the safety data on the use the
drugs.
PROGRAM COMPONENTS
• The Philippine Plan was approved by WHO which gave the
government free supply of Albendazole (donated by GSK thru
WHO) for filariasis elimination.
• An administrative order declaring “November as Filariasis Mass
Treatment Month” was signed by the Secretary of Health was
issued on that same year.
• In 2010, a guideline in the prevention of disabilities due to
lymphatic filariasis in support to effective implementation of
management of morbidity and prevention of disabilities due to
filariasis.
STRATEGIES
1. Mass Drug Administration
2. Disability Management
3. Monitoring thru Midterm Sentinel surveys
and Evaluation thru Transmission Assessment
Survey
4. Post Validation Surveillance
5. Private-Public Partnership

S-ar putea să vă placă și